Sevo Nutraceuticals
Holden
About Sevo Nutraceuticals
Sevo Nutraceuticals is a medical company that was launched in June 2012 that develops efficacious, science-backed nutraceuticals that improve people's lives. In August 2012, the company launched its flagship product, PERCEPTIV®. PERCEPTIV® is a patented formula based on research that was funded by UMASS Lowell, the Alzheimer's Association, the National Institute on Aging, and the National Science Foundation. UMASS Lowell licensed the intellectual property including patents, a trademark, and know-how to Sevo in June 2012. Bernie Prusaczyk, Chief Executive Officer, is an experienced entrepreneur and business executive with over 25 years' experience in sales, marketing, and business development. He has been at the core of several start-ups from pre-revenue to rapid revenue growth and successful exits.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $300.0K
- Last round: Equity Crowdfunding (Jan 2015)
- Website: sevonutraceuticals.com
- Phone: +1 (508) 755-7257
Industries & Categories
Biotechnology, Medical, Nutraceutical
Social Profiles
Canonical: https://fsome.com/organization/sevo-nutraceuticals-2826911 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.